Thoratec Corporation, (THOR), which engages in the development, manufacture, and marketing of proprietary medical devices used for circulatory support, Friday announced that it has received approval from the U.S. Food and Drug Administration to market the HeartMate II Pocket Controller, the small, smart, safe face of the HeartMate II LVAD System.
The Pocket Controller is designed to support the active lifestyles that patients with HeartMate II LVADs are leading. The Pocket Controller is lighter and more compact than previous LVAD system controllers, and it features an intuitive user interface with enhanced information content.
"...We have a significant amount of clinical experience and patient feedback from Europe that has highlighted the Pocket Controller's ability to deliver meaningful benefits in everyday living with this therapy." said Gary Burbach, President and Chief Executive Officer.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.